Benzonatate
- Product NDC
- 70934-893
- 11-digit product format
- 709340893
- Labeler code
- 70934
- Product ID
- 70934-893_e3d9ab6d-8da3-0680-e053-2a95a90aa315
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA206948
- Marketing category
- ANDA
- Marketing start
- 2021-09-16
- Marketing end
- 2024-03-31
- Substance
- BENZONATATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-893-09 | 70934089309 | 9 CAPSULE in 1 BOTTLE, PLASTIC (70934-893-09) | 9 capsule | 2022-05-25 | 0000-00-00 | No | No | Current |
| 70934-893-15 | 70934089315 | 15 CAPSULE in 1 BOTTLE, PLASTIC (70934-893-15) | 15 capsule | 2022-02-03 | 0000-00-00 | No | No | Current |
| 70934-893-21 | 70934089321 | 21 CAPSULE in 1 BOTTLE, PLASTIC (70934-893-21) | 21 capsule | 2022-07-14 | 2024-03-31 | No | No | Current |
| 70934-893-30 | 70934089330 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-893-30) | 30 capsule | 2021-09-16 | 0000-00-00 | No | No | Current |